Dr. Bruce G. Thorkildsen, MD

Dr. Thorkildsen practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Thorkildsen's NPI, 1215970769, was assigned on June 13, 2006. Dr. Thorkildsen holds Pennsylvania license MD046529L.

Dr. Thorkildsen's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Thorkildsen's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Thorkildsen is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Thorkildsen to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thorkildsen practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Thorkildsen's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Thorkildsen's licenses on file in 2 states: Pennsylvania and New York.

CMS data shows 3,042 Medicare services from Dr. Thorkildsen across 19 procedure codes in 2024, for 402 Medicare patients. Medicare paid $147,871 for them.

CMS counts 402 Medicare patients who saw Dr. Thorkildsen in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thorkildsen's median patient age at 72, with 56% women.

In 2024, Dr. Thorkildsen wrote 9,330 Medicare Part D claims for 513 patients. 89% of them were for generic drugs. CMS names the drug for 8,467 of them, across 156 drugs with 11 or more claims each, at $543,212 in total drug cost. In 2023, CMS named 7,299 claims across 148 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Thorkildsen for performance year 2024, reported through an alternative payment model (APM). Dr. Thorkildsen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thorkildsen as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 82 general payments to Dr. Thorkildsen from 16 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $549.